Free Trial

Primecap Management Co. CA Purchases New Holdings in Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background
Remove Ads

Primecap Management Co. CA acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,079,416 shares of the company's stock, valued at approximately $37,118,000. Primecap Management Co. CA owned about 6.19% of Grail at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. FNY Investment Advisers LLC acquired a new stake in Grail during the fourth quarter valued at $26,000. Lindbrook Capital LLC acquired a new stake in Grail during the fourth quarter valued at $28,000. Wellington Shields Capital Management LLC acquired a new stake in Grail during the fourth quarter valued at $33,000. New York State Common Retirement Fund acquired a new stake in Grail during the fourth quarter valued at $59,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Grail during the fourth quarter valued at $64,000.

Grail Price Performance

Shares of NASDAQ:GRAL traded up $2.48 on Friday, reaching $30.29. The company had a trading volume of 1,739,247 shares, compared to its average volume of 1,224,238. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The stock has a 50-day moving average price of $32.87 and a 200 day moving average price of $21.79.

Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. On average, equities research analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley boosted their price target on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday.

Read Our Latest Report on GRAL

Insider Transactions at Grail

In other news, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares in the company, valued at approximately $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,550 shares of company stock worth $360,436.

About Grail

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Recommended Stories

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads